Dropping the Mic on Demodex: The Final Word by Dr. Bobby Azamian on Blepharitis

Dry Eye Coach
Dry Eye Coach
Dropping the Mic on Demodex: The Final Word by Dr. Bobby Azamian on Blepharitis
/

Dr. Whitley talks with Dr. Bobby Azamian, co-founder, president and CEO of Tarsus Pharmaceuticals, about a topic that we haven’t addressed before on the Dry Eye Coach Podcast, which is addressing an unmet need for 25 million Americans: Demodex blepharitis.

Tarsus is developing TP-03, which is a drug that has the potential to be the first FDA approved treatment for Demodex Blepharitis.

Click Here to read the transcript of this podcast.

OUR COACHES